Medical News

RSS

Study suggests friendship can provide an alternative to eating and help promote active lifestyles

Parents are acutely aware of the influence of friends on their children's behavior -- how they dress, how they wear their hair, whether they drink or smoke.

12 Jan 2010

In weekly address, Obama focuses on immediate benefits of health bill

"President Obama said Saturday that Americans would see immediate benefits from a landmark overhaul of the nation's health insurance system, and he urged Congress to reconcile swiftly differences on the legislation so it could be signed into law in the coming weeks," The New York Times reports.

12 Jan 2010

BioMarin Pharmaceutical commences BMN 195 Phase 1 clinical study for DMD

BioMarin Pharmaceutical Inc. announced today that the first subject has initiated treatment in the Phase 1 clinical study of BMN 195, a small molecule utrophin upregulator, for the treatment of Duchenne muscular dystrohpy (DMD). Initial top-line results are expected in the third quarter of 2010.

12 Jan 2010

Obama to meet with labor leaders to push 'Cadillac' tax in health overhaul legislation

"President Barack Obama, facing growing resistance among Democrats over his support for taxing health benefits, will confront U.S. labor leaders and House lawmakers this week on the issue."

11 Jan 2010

AASLD supports IOM study that recommends ways to reduce viral hepatitis B and C

The American Association for the Study of Liver Disease (AASLD) today reacted favorably to the release by they Institute of Medicine (IOM) of the report of "Hepatitis and Liver Cancer: A National Strategy for Prevention and Control of Hepatitis B and C." This landmark study evaluated the burden from viral hepatitis and current preventive and management practices and recommended ways to reduce new cases of hepatitis B and C and morbidity and mortality from chronic disease.

11 Jan 2010

PhotoMedex, Galderma Laboratories enter into co-promotion agreement for photodynamic therapy application

PhotoMedex and Galderma Laboratories, L.P. have entered into a co-promotion agreement for Galderma’s photodynamic therapy application for the treatment of actinic keratoses (“AK”).

11 Jan 2010

Study demonstrates benefits of allergen immunotherapy for children with allergic rhinitis

Allergy immunotherapy, generally referred to as allergy vaccinations or shots, reduce total health care costs in children with allergic rhinitis (hay fever) by one-third, and prescription costs by 16 percent, according to a study published this month in Annals of Allergy, Asthma & Immunology, the scientific journal of the American College of Allergy, Asthma and Immunology (ACAAI).

11 Jan 2010

Positive top-line results from Protox Therapeutics' Phase 2b study of PRX302 announced

Protox Therapeutics Inc., a leader in the development of receptor targeted fusion proteins, today announced positive top-line results from its double-blinded placebo controlled Phase 2b study of PRX302 (study name: TRIUMPH) in patients with moderate to severe benign prostatic hyperplasia (BPH), a painful and bothersome urological condition that affects more than 50 million men worldwide.

11 Jan 2010

MedAssets and TPC sign multi-year agreement

MedAssets, Inc. today announced that the Texas Purchasing Coalition (TPC) has signed a multi-year agreement to utilize and benefit from MedAssets’ strategic supply chain solutions, including group purchasing (GPO) services, physician preference item (PPI) consulting services and spend management analytics. The

11 Jan 2010

Sangamo BioSciences initiates two new clinical trials of ZFP Therapeutics

Sangamo BioSciences, Inc. announced the initiation of two new clinical trials of ZFP Therapeutics, a Phase 2b study in diabetic neuropathy (DN) and a Phase 1 trial in glioblastoma, as well as the renewal of $3.0 million in funding for the Phase 2b trial by the Juvenile Diabetes Research Foundation International (JDRF).

11 Jan 2010

Los Angeles International Airport offers H1N1 flu shots in airline terminals

Los Angeles International Airport (LAX), in partnership with FLU*Ease, Inc., is now offering flu shots to travelers in most of the airline terminals as a public safety measure against the flu, especially the H1N1 strain.)

11 Jan 2010

Cubist Pharmaceuticals reports total revenues for fourth-quarter and full-year 2009

Cubist Pharmaceuticals, Inc. today announced total revenues for both the fourth quarter and full year ended December 31, 2009.

11 Jan 2010

Exercise may improve cognitive function

Moderate physical activity performed in midlife or later appears to be associated with a reduced risk of mild cognitive impairment, whereas a six-month high-intensity aerobic exercise program may improve cognitive function in individuals who already have the condition, according to two reports in the January issue of Archives of Neurology, one of the JAMA/Archives journals.

11 Jan 2010

State Radio in China to launch HIV/AIDS educational program

China National Radio (CNR) on Jan. 16 is set to air a weekly one-hour program aimed at increasing HIV/AIDS awareness, Xinhua reports. People living with HIV will help co-host the program - "Positive Talks" - which will feature communication between hosts and the audience as well as experts on HIV/AIDS prevention and more, Yang Wenyan, deputy editor-in-chief of CNR, said Saturday.

11 Jan 2010

Targacept signs collaboration and license agreement with AstraZeneca

Targacept, Inc., a clinical-stage biopharmaceutical company developing a new class of drugs known as NNR Therapeutics™, today announced that its collaboration and license agreement with AstraZeneca for the global development and commercialization of TC-5214 for major depressive disorder (MDD) has become effective as a result of early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act.

11 Jan 2010

Coalition will respond to IOM report on viral hepatitis and support CDC research and programs

In anticipation of the release of the Institute of Medicine (IOM) report on viral hepatitis, the CDC Foundation (the independent nonprofit partner of the Centers for Disease Control and Prevention), in partnership with CDC's Division of Viral Hepatitis, recently launched the Viral Hepatitis Action Coalition.

11 Jan 2010

CMS study finds Senate health bill would increase costs less steeply than thought

A report from the Center on Medicare and Medicaid Services finds that the Senate health bill would increase health care spending less steeply than previously thought.

11 Jan 2010

Amarin commences enrollment in its AMR101 Phase 3 clinical trials for cardiovascular disease

Amarin Corporation plc, a clinical-stage biopharmaceutical company focused on improving the treatment of cardiovascular disease, today announced that first patients were enrolled in the MARINE and ANCHOR Phase 3 clinical trials for AMR101, the Company's lead product candidate. These clinical trials are designed to demonstrate that AMR101 lowers triglyceride levels in patients with very high triglycerides (the MARINE Study) and high triglycerides in patients with mixed dyslipidemia being treated with statins (the ANCHOR Study).

11 Jan 2010

New data from phase 3 study of avanafil for treatment of ED announced

VIVUS, Inc. today announced new data from an analysis of the recently completed phase 3 study (REVIVE TA-301) of avanafil, an investigational drug candidate for the treatment of erectile dysfunction (ED).

11 Jan 2010

Albertsons launches new online community to provide value-driven choices for healthier living

Albertsons, a SUPERVALU company, today launched a new online community, AlbertsonsWellbeing.com, that will provide users with tools to help them make easy, value-driven choices for healthier living.

11 Jan 2010

Medical News

Study suggests friendship can provide an alternative to eating and help promote active lifestyles

In weekly address, Obama focuses on immediate benefits of health bill

BioMarin Pharmaceutical commences BMN 195 Phase 1 clinical study for DMD

Obama to meet with labor leaders to push 'Cadillac' tax in health overhaul legislation

AASLD supports IOM study that recommends ways to reduce viral hepatitis B and C

PhotoMedex, Galderma Laboratories enter into co-promotion agreement for photodynamic therapy application

Study demonstrates benefits of allergen immunotherapy for children with allergic rhinitis

Positive top-line results from Protox Therapeutics' Phase 2b study of PRX302 announced

MedAssets and TPC sign multi-year agreement

Sangamo BioSciences initiates two new clinical trials of ZFP Therapeutics

Los Angeles International Airport offers H1N1 flu shots in airline terminals

Cubist Pharmaceuticals reports total revenues for fourth-quarter and full-year 2009

Exercise may improve cognitive function

State Radio in China to launch HIV/AIDS educational program

Targacept signs collaboration and license agreement with AstraZeneca

Coalition will respond to IOM report on viral hepatitis and support CDC research and programs

CMS study finds Senate health bill would increase costs less steeply than thought

Amarin commences enrollment in its AMR101 Phase 3 clinical trials for cardiovascular disease

New data from phase 3 study of avanafil for treatment of ED announced

Albertsons launches new online community to provide value-driven choices for healthier living

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Latest News